OXIDE Corporation
6521・Growth Market・Electric Appliances
Business
OXIDE Corporation is an optical specialty manufacturer founded in 2000 that develops, manufactures, and sells optical components, laser light sources, and optical measurement equipment, built around its single crystal growth technology. The business is composed of three segments: "Semiconductor Business" (net sales of ¥4,703 million), "New Business" (¥2,464 million), and "Healthcare Business" (¥1,226 million). Major customers include semiconductor wafer inspection equipment manufacturers, PET inspection equipment manufacturers, and optical device manufacturers for data centers, among others. In 2014, the company was selected for the Ministry of Economy, Trade and Industry's "Global Niche Top 100" list. It possesses a diverse range of single crystal growth technologies including the FZ method, CZ method, and KY method, and is an R&D-driven company that operates across the entire optical value chain from upstream to downstream.
Business Model
Starting from single crystal development and manufacturing positioned upstream in the optical value chain, the company expands downstream into optical components, laser light sources, and optical measurement instruments. In the semiconductor business, the company repeats a cycle of "development contracting → transition to mass production," with a structure in which maintenance demand (approximately 16% of semiconductor business revenue) accumulates as recurring revenue as cumulative shipment volumes increase. In the new business domain, the company plays an incubation role, nurturing future mass-production businesses through prototype and development contracting work.
Company Strengths
The company possesses eight or more single crystal growth technologies and equipment, including the FZ method, CZ method, VB method, TSSG method, DCCZ method, KY method, EFG method, and flux method. It was selected for the Ministry of Economy, Trade and Industry's "Global Niche Top 100" in 2014, and continues to receive ongoing inquiries regarding its technologies and products from domestic and overseas companies, universities, and research institutes.
Holders of doctoral and master's degrees in engineering and science account for 23% of officers and employees engaged in research and development and manufacturing. The company hires doctoral program graduates every year, with 22 new graduate hires in April 2023 and 25 in April 2024, continuing to accumulate technical expertise as a research and development-driven operating company.
Single crystals and lasers installed in semiconductor wafer inspection equipment generate demand for periodic maintenance every one to two years. Maintenance revenue in the fiscal year under review accounted for approximately 16% of semiconductor business sales, functioning as a stabilizing factor for earnings amid the highly volatile semiconductor market. Further expansion is expected in the future as cumulative shipment volumes increase.
ENVALITH's Perspective
Performance Trend
Revenue rose for four consecutive periods: ¥4,757 million in FY2022 → ¥5,753 million in FY2023 → ¥6,607 million in FY2024 → ¥8,395 million in FY2025 → ¥10,040 million in FY2026. In Q1 of FY2027 (ending March 2027)... [note: fiscal period appears to be FY2027 ending February 2027], revenue reached ¥2,192 million (up 22.6% year-on-year), maintaining the growth trend backed by a strong semiconductor market (an external factor being expanding demand for advanced semiconductor inspection equipment driven by the spread of generative AI). Operating profit swung to a profit of ¥199 million from a loss of ¥72 million in the same period of the previous year, with ordinary profit of ¥145 million and quarterly net profit attributable to owners of the parent of ¥70 million secured. The disappearance of the ¥149 million foreign exchange loss that occurred in the same period of the previous year also contributed significantly to the improvement in ordinary profit/loss. There has been no change to the full-year earnings forecast (revenue of ¥9,828 million, operating profit of ¥933 million, net profit of ¥597 million), and the challenge remains to continue achieving profitability in order to eliminate the accumulated deficit in retained earnings.
Growth Strategy
Revenue diversification through expansion of the three businesses of Semiconductor, Healthcare, and New Fields, along with entry into new business domains
In response to the expanding market for advanced semiconductor inspection equipment driven by the spread of generative AI, the company is promoting increased demand for existing Deep-UV Laser / Single Crystal products as well as the launch of new products. In the first quarter of FY2027 (ending February 2027), sales significantly exceeded expectations, with the Semiconductor Business functioning as a driver of overall performance.
The strategy is to capture growing demand for head-dedicated PET devices, driven by the pharmaceutical approval of Alzheimer's disease treatment drugs and the insurance coverage of PET diagnostics. In the first quarter of FY2027 (ending February 2027), some shipments were deferred to the second quarter and beyond, resulting in results below expectations; the company continues discussions with customers regarding transaction terms in response to changes in the procurement environment and rising prices of key raw materials.
Against the backdrop of growing global demand for data centers, the company aims to increase shipments of Faraday rotators. In the first quarter of FY2027 (ending February 2027), sales originally planned for the first quarter were deferred to the second quarter due to delays in materials arrival; however, this is considered a temporary factor, and the sales are expected to be recognized from the second quarter onward.
The company significantly reduced selling, general and administrative expenses from ¥873 million in the same period of the previous year to ¥612 million, while improving its earnings structure by increasing the sales composition ratio of higher-margin products. In the first quarter of FY2027 (ending February 2027), the results became evident, with operating profit turning positive at ¥199 million.
Last updated: July 17, 2026